September, 2022: Ad-Hoc Booster Grant to Advanced Translational Research on anti-viral T-cell products: From plate to closed G-Rex to bedside
Among the winning projects, the highest rated idea aimed to translate existing manufacturing processes for antiviral T-cells into a fully automated system that ultimately reduces the risk for contamination and decreases manual work and variation.
to BIH – Center for Regenerative Therapies (BCRT) website